Slika omota

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.

Pokaži ostale verzije (1)

Fractional dosing of COVID-19 vaccines could accelerate vaccination rates in low-income countries. Dose-finding studies of the mRNA vaccine BNT162b2 (Pfizer-BioNTech) suggest that a fractional dose induces comparable antibody responses to the full dose in people <55 years. Here, we report the saf...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Pieter Pannus (Autor), Stéphanie Depickère (Autor), Delphine Kemlin (Autor), Sarah Houben (Autor), Kristof Y Neven (Autor), Leo Heyndrickx (Autor), Johan Michiels (Autor), Elisabeth Willems (Autor), Stéphane De Craeye (Autor), Antoine Francotte (Autor), Félicie Chaumont (Autor), Véronique Olislagers (Autor), Alexandra Waegemans (Autor), Mathieu Verbrugghe (Autor), Marie-Noëlle Schmickler (Autor), Steven Van Gucht (Autor), Katelijne Dierick (Autor), Arnaud Marchant (Autor), Isabelle Desombere (Autor), Kevin K Ariën (Autor), Maria E Goossens (Autor)
Format: Knjiga
Izdano: Public Library of Science (PLoS), 2022-01-01T00:00:00Z.
Teme:
article
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno

Slični predmeti